Role of ERK1/2 in the anti-apoptotic and cardioprotective effects of nitric oxide after myocardial ischemia and reperfusion

Apoptosis

Volumn 11, Issue 6, 2006, Pages 923-930

  Li, D Y ^a,b   Tao, L ^a   Liu, H ^a   Christopher, T A ^a   Lopez, B L ^a   Ma, X L ^a,c  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b FUWAI HOSPITAL   (China)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Apoptosis; ERK1 2; Myocardial ischemia reperfusion; Nitric oxide

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; CASPASE 3; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; HEART; HEART FUNCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ANIMALS; APOPTOSIS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; MALE; MICE; MICE, INBRED C57BL; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NITRIC OXIDE;

ANIMALIA;

EID: 33745032835     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-006-6305-6     Document Type: Article

References (30)

1. Gottlieb RA, Engler RL. Apoptosis in myocardial ischemia-reperfusion. Ann NY Acad Sci 1999; 874: 412-426.
2. Paulus WJ. The role of nitric oxide in the failing heart. Heart Fail Rev 2001; 6: 105-118.
3. Marletta MA, Maxey KM. Nitric oxide: function, Formation and therapeutic potential. Cayman Chemical 1995; 1: 1-5.
4. Liu GL, Christopher TA, Lopez BL, et al. SP/W-5186, a cysteine-containing nitric oxide donor, attenuates post-ischemic myocardial injury. J Pharm Experim Therap 1998; 287: 527-537.
5. Johnson GL, Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002; 298: 1911-1912.
6. Abe Ji, Baines CP, Berk BC. Role of mitogen-activated protein kinases in ischemia and reperfusion injury : The good and thebad. Circul Res 2000; 86: 607-609.
7. Yue TL, Wang C, Gu JL, et al. Inhibition of extracellular signal-regulated kinase enhances ischemia/reoxygenation-induced apoptosis in cultured cardiac myocytes and exaggerates reperfusion injury in isolated perfused heart. Circ Res 2000; 86: 692-699.
8. Ma XL, Kumar S, Gao F, et al. Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion. Circulation 1999; 99: 1685-1691.
9. Chae HJ, Kim HR, Kwak YG, Ko JK, Joo CU, Chae SW. Signal transduction of nitric oxide donor-induced protection in hydrogen peroxide-mediated apoptosis in H9C2 cardiomyoblasts. Immunopharm Immunotox 2001; 23: 187-204.
10. Rakhit RD, Kabir AN, Mockridge JW, Saurin A, Marber MS. Role of G proteins and modulation of p38 MAPK activation in the protection by nitric oxide against ischemia-reoxygenation injury. Biochem Biophys Res Commun 2001; 286: 995-1002.
11. Yun HY, Gonzalez-Zulueta M, Dawson VL, Dawson TM. Nitric oxide mediates N-methyl-D-aspartate receptor-induced activation of p21ras. Proc Natl Acad Sci USA 1998; 95: 5773-5778.
12. Boyd CS, Cadenas E. Nitric oxide and cell signaling pathways in mitochondrial-dependent apoptosis. Biol Chem 2002; 383: 411-423.
13. Rossig L, Haendeler J, Hermann C, et al. Nitric oxide down-regulates MKP-3 mRNA levels: involvement in endothelial cell protection from apoptosis. J Biol Chem 2000; 275: 25502-25507.
14. Gao F, Gao E, Yue TL, et al. Nitric oxide mediates the anti-apoptotic effect of insulin in myocardial ischemia-reperfusion: the roles of PI3-kinase, Akt, and endothelial nitric oxide synthase Phosphorylation. Circulation 2002; 105: 1497-1502.
15. Liu HR, Tao L, Gao E, et al. Anti-apoptotic effects of rosiglitazone in hypercholesterolemic rabbits subjected to myocardial ischemia and reperfusion. Cardiovasc Res 2004; 62: 135-144.
16. Tao L, Gao E, Bryan NS, et al. Cardioprotective effects of thioredoxin in myocardial ischemia and reperfusion: Role of S-nitrosation. Proc Nat Acad Sci 2004; 101: 11471-11476.
17. Frodin M, Gammeltoft S. Role and regulation of 90 kDa ribosomal S6 kinase (RSK) in signal transduction. Mol Cell Endocr 1999; 151: 65-77.
18. Takahashi E, Abe Ji, Gallis B et al. p90RSK is a serum-stimulated Na+/H+ exchanger isoform-1 kinase. Regulatory Phosphorylation of Serine 703 of Na+/H+ exchanger isoform-1. J Biol Chem 1999; 274: 20206-20214.
19. Fang X, Yu S, Eder A, et al. Regulation of BAD phosphorylation at serine 112 by the Ras-mitogen- activated protein kinase pathway. Oncogene 1999; 18: 6635-6640.
20. Scheid MP, Schubert KM, Duronio V. Regulation of bad phosphorylation and association with Bcl-x(L) by the MAPK/Erk kinase. J Biol Chem 1999; 274: 31108-31113.
21. Scheid MP, Schubert KM, Duronio V. Regulation of bad phosphorylation and association with Bcl-xL by the MAPK/Erk kinase. J Biol Chem 1999; 274: 31108-31113.
22. Scheid MP, Duronio V. Dissociation of cytokine-mduced phosphorylation of Bad and activation of PKB/akt: Involvement of MEK upstream of bad phosphorylation. Proc Nat Acad Sci 1998; 95: 7439-7444.
23. Baines CP, Zhang J, Wang GW, et al. Mitochondrial PKC{epsilon} and MAPK Form Signaling Modules in the Murine Heart: Enhanced mitochondrial PKC{epsilon}-MAPK interactions and differential MAPK activation in PKC{epsilon}-induced cardioprotection. Circul Res 2002; 90: 390-397.
24. Bonni A, Brunet A, West AE, Datta SR, Takasu MA, Greenberg ME. Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science 1999; 286: 1358-1362.
25. Tan Y, Ruan H, Demeter MR, Comb MJ. p90RSK blocks bad-mediated cell death via a protein kinase C-dependent pathway. J Biol Chem 1999; 274: 34859-34867.
26. Weyrich AS, Ma XL, Lefer AM. The role of L-arginine in ameliorating reperfusion injury after myocardial ischemia in the cat. Circulation 1992; 86: 279-288.
27. Beckman JS. Parsing the effects of nitric oxide, S-nitrosothiols, and peroxynitrite on inducible nitric oxide synthase-dependent cardiac myocyte apoptosis. Circulation Reserach 1999; 85: 870-871.
28. Chung HT, Pae HO, Choi BM, Billiar TR, Kim YM. Nitric oxide as a bioregulator of apoptosis. Biochem Biophys Res Commun 2001; 282: 1075-1079.
29. Muda M, Boschert U, Dickinson R, et al. MKP-3, a novel cytosolic protein-tyrosine phosphatase that exemplifies a new class of mitogen-activated protein kinase phosphatase. J Biol Chem 1996; 271: 4319-4326.
30. Callsen D, Pfeilschifter J, Brune B. Rapid and delayed p42/p44 mitogen-activated protein kinase activation by nitric oxide: the role of cyclic GMP and tyrosine phosphatase inhibition. J Immunol 1998; 161: 4852-4858.